|
1
|
Passarello K, Kurian S and Villanueva V:
Endometrial cancer: An overview of pathophysiology, management, and
care. Semin Oncol Nurs. 35:157–165. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dai D, Wolf DM, Litman ES, White MJ and
Leslie KK: Progesterone inhibits human endometrial cancer cell
growth and invasiveness: Down-regulation of cellular adhesion
molecules through progesterone B receptors. Cancer Res. 62:881–886.
2002.PubMed/NCBI
|
|
3
|
Baker J, Obermair A, Gebski V and Janda M:
Efficacy of oral or intrauterine device-delivered progestin in
patients with complex endometrial hyperplasia with atypia or early
endometrial adenocarcinoma: A meta-analysis and systematic review
of the literature. Gynecol Oncol. 125:263–270. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chae-Kim J, Garg G, Gavrilova-Jordan L,
Blake LE, Kim TT, Wu Q and Hayslip CC: Outcomes of women treated
with progestin and metformin for atypical endometrial hyperplasia
and early endometrial cancer: A systematic review and
meta-analysis. Int J Gynecol Cancer. 31:1499–1505. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu XH, Li T, Fong CM, Chen X, Chen XJ,
Wang YT, Huang MQ and Lu JJ: Saponins from Chinese medicines as
anticancer agents. Molecules. 21:13262016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li J, Jia J, Zhu W, Chen J, Zheng Q and Li
D: Therapeutic effects on cancer of the active ingredients in
rhizoma paridis. Front Pharmacol. 14:10957862023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao L, Liu Z, Deng X, Wang J, Sun L, Fan
L and Zhang Y: Polyphyllin VII induces mitochondrial apoptosis by
regulating the PP2A/AKT/DRP1 signaling axis in human ovarian
cancer. Oncol Rep. 45:513–522. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du SG, Zhang HM, Ji YX, Tian YL, Wang D,
Zhu K, Zhang QG and Liu SP: Polyphyllin VII promotes apoptosis in
breast cancer by inhibiting MAPK/ERK signaling pathway through
downregulation of SOS1. Am J Chin Med. 52:885–904. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu L, Chen Z, Wang Y, Li Y, Wang Z, Li F
and Xi X: Polyphyllin VII as a potential drug for targeting
stemness in hepatocellular cancer via STAT3 signaling. Curr Cancer
Drug Targets. 23:325–331. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hill M and Tran N: miRNA interplay:
Mechanisms and consequences in cancer. Dis Model Mech.
14:dmm0476622021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang C, Xie S, Yuan S, Zhang Y, Bai Y,
Chu L, Wu Z, Guo N, Wang Q and Zhang J: Metabotropic glutamate
receptor 8 is regulated by miR-33a-5p and functions as an oncogene
in breast cancer. J Oncol. 14:80020872021.PubMed/NCBI
|
|
13
|
Yan Y, Zhang D, Lei T, Zhao C, Han J, Cui
J and Wang Y: MicroRNA-33a-5p suppresses colorectal cancer cell
growth by inhibiting MTHFD2. Clin Exp Pharmacol Physiol.
46:928–936. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao C, Wei J, Tang T and Huang Z: Role of
microRNA-33a in malignant cells. Oncol Lett. 20:2537–2556. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xing W, Li T, Wang Y, Qiang Y, Ai C and
Tang H: MiR-33a-5p targets NOMO1 to modulate human cardiomyocyte
progenitor cells proliferation and differentiation and apoptosis. J
Recept Signal Transduct Res. 41:476–487. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu H, Han L, Zhong L, Zhuang X and Peng
Y: FBXL16 promotes endometrial progesterone resistance via
PP2A(B55α)/Cyclin D1 axis in Ishikawa. J Immunol Res.
2022:73722022022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao F, Pan C, Zhang Y, Yang J and Xing X:
Polyphyllin VII alleviates pulmonary hypertension by inducing
miR-205-5p to target the β-catenin pathway. Biomed Pharmacother.
167:1155162023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Zhang L, Che X, Li W, Liu Z and
Jiang J: Roles of SIRT1/FoxO1/SREBP-1 in the development of
progestin resistance in endometrial cancer. Arch Gynecol Obstet.
298:961–969. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cui Y, Wu H, Yang L, Huang T, Li J, Gong
X, Li L, Sun X, Mao F and Wang Y: Chlorpromazine sensitizes
progestin-resistant endometrial cancer cells to MPA by upregulating
PRB. Front Oncol. 11:6658322021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Murakami H, Hayashi M, Terada S and
Ohmichi M: Medroxyprogesterone acetate-resistant endometrial cancer
cells are susceptible to ferroptosis inducers. Life Sci.
325:1217532023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Crosbie EJ, Kitson SJ, McAlpine JN,
Mukhopadhyay A, Powell ME and Singh N: Endometrial cancer. Lancet.
399:1412–1428. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Que Z, Luo B, Yu P, Qi D, Shangguan W,
Wang P, Liu J, Li Y, Li H, Ke R, et al: Polyphyllin VII induces CTC
anoikis to inhibit lung cancer metastasis through EGFR pathway
regulation. Int J Biol Sci. 19:5204–5217. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiang Y, Wan F, Ren Y, Yang D, Xiang K,
Zhu B, Ruan X, Li S, Zhang L, Liu X, et al: Polyphyllin VII induces
autophagy-dependent ferroptosis in human gastric cancer through
targeting T-lymphokine-activated killer cell-originated protein
kinase. Phytother Res. 37:5803–5820. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song C, Pan B, Yang X and Tang W:
Polyphyllin VII suppresses cell proliferation, the cell cycle and
cell migration in colorectal cancer. Oncol Lett.
21:252021.PubMed/NCBI
|
|
26
|
Zhang C, Li C, Jia X, Wang K, Tu Y, Wang
R, Liu K, Lu T and He C: In Vitro and in vivo anti-inflammatory
effects of polyphyllin VII through downregulating MAPK and NF-κB
pathways. Molecules. 24:8752019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang C, Jia X, Wang K, Bao J, Li P, Chen
M, Wan JB, Su H, Mei Z and He C: Polyphyllin VII induces an
autophagic cell death by activation of the JNK pathway and
inhibition of PI3K/AKT/mTOR pathway in HepG2 cells. PLoS One.
11:e01474052016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee MS, Yuet-Wa JC, Kong SK, Yu B,
Eng-Choon VO, Nai-Ching HW, Chung-Wai TM and Fung KP: Effects of
polyphyllin D, a steroidal saponin in Paris polyphylla, in growth
inhibition of human breast cancer cells and in xenograft. Cancer
Biol Ther. 4:1248–1254. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang W, Zhang D, Ma X, Liu Z, Li F and Wu
D: Paris saponin VII suppressed the growth of human cervical cancer
Hela cells. Eur J Med Res. 19:412014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cassier PA, Navaridas R, Bellina M, Rama
N, Ducarouge B, Hernandez-Vargas H, Delord JP, Lengrand J, Paradisi
A, Fattet L, et al: Netrin-1 blockade inhibits tumour growth and
EMT features in endometrial cancer. Nature. 620:409–416. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ashrafizadeh M, Zarrabi A, Hushmandi K,
Kalantari M, Mohammadinejad R, Javaheri T and Sethi G: Association
of the epithelial-mesenchymal transition (EMT) with cisplatin
resistance. Int J Mol Sci. 21:40022020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pan J, Fang S, Tian H, Zhou C, Zhao X,
Tian H, He J, Shen W, Meng X, Jin X and Gong Z: lncRNA
JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis
of lung cancer by activating Wnt/β-catenin signaling. Mol Cancer.
19:92020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo XF, Wang AY and Liu J:
HIFs-MiR-33a-Twsit1 axis can regulate invasiveness of
hepatocellular cancer cells. Eur Rev Med Pharmacol Sci.
20:3011–3016. 2016.PubMed/NCBI
|
|
34
|
Cao D, Wang J, Ji Z, Shangguan Y, Guo W,
Feng X, Xu K and Yang J: Profiling the mRNA and miRNA in peripheral
blood mononuclear cells in subjects with active tuberculosis.
Infect Drug Resist. 13:4223–4234. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ghosh N, Saha I, Sharma N and Sarkar JP:
Human miRNAs to identify potential regions of SARS-CoV-2. ACS
Omega. 7:21086–21101. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim YJ, Zhao Y, Myung JK, Yi JM, Kim MJ
and Lee SJ: Suppression of breast cancer progression by FBXL16 via
oxygen-independent regulation of HIF1α stability. Cell Rep.
37:1099962021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pan J, Zhou C, Zhao X, He J, Tian H, Shen
W, Han Y, Chen J, Fang S, Meng X, et al: A two-miRNA signature
(miR-33a-5p and miR-128-3p) in whole blood as potential biomarker
for early diagnosis of lung cancer. Sci Rep. 8:166992018.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Costa V, De Fine M, Carina V, Conigliaro
A, Raimondi L, De Luca A, Bellavia D, Salamanna F, Alessandro R,
Pignatti G, et al: How miR-31-5p and miR-33a-5p regulates SP1/CX43
expression in osteoarthritis disease: Preliminary insights. Int J
Mol Sci. 22:24712021. View Article : Google Scholar : PubMed/NCBI
|
